Pharmacotherapy of atrial fibrillation

dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDepartment of pharmacologyhu_HU
dc.contributor.authorÁsbjörnsson, Björn Orri
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKözponti Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2019-09-20T10:04:06Z
dc.date.available2019-09-20T10:04:06Z
dc.date.created2019
dc.description.abstractIn this thesis the epidemiology, etiology, pathophysiology and classification of AF will be illustrated. The main focus of this thesis however is the discussion of the treatment options available with special focus on the pharmacologic treatment options. Whether to choose a rate control strategy or rhythm control strategy will be considered as well as what drugs are available in each category. Non-pharmacologic methods of rhythm control will also be discussed shortly. Anticoagulation therapy is an important part of AF treatment, as AF is known to increase the risk of ischemic stroke. The indications and contraindications to anticoagulation therapy will be debated as well as the treatment options available, with comparison of the classically used warfarin with the newer novel oral anticoagulant drug and anti-platelet agents.hu_HU
dc.description.correctorLB
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273613
dc.language.isoenhu_HU
dc.subjectAtrial fibrillationhu_HU
dc.subjectAnti-coagulationhu_HU
dc.subjectRate controlhu_HU
dc.subjectRhythm controlhu_HU
dc.subjectThromboembolismhu_HU
dc.subjectAntiarrhythmichu_HU
dc.subject.dspacePharmacologyhu_HU
dc.titlePharmacotherapy of atrial fibrillationhu_HU
Fájlok